July 8, 2010 – The Canadian Nuclear Safety Commission (CNSC) announced this week it has authorized the reactivation of the National Research Universal (NRU) reactor in Chalk River, Ontario, Canada. It is estimated that NRU will resume medical isotope production by the end of July, after being shut down in 2009 for several repairs.

The Atomic Energy of Canada Limited (AECL) appeared before the Canadian Nuclear Safety Commission (CNSC) on July 5 in a public hearing to consider AECL’s application to restart the reactor. During the hearing, AECL presented its case on NRU’s readiness to resume safe operation and the path forward for planned operation and maintenance of the reactor. Progress is being made on completing the many tests, system configurations and tasks required prior to actual restart of NRU. These activities will continue over the next few weeks.

The reactor produces most of the medical isotopes for Canada and the United States. The reactor produces molybdenum-99 (Mo-99), used to produce technetium-99 used in diagnostic nuclear imaging scans.


Related Content

News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | PET Imaging

May 29, 2026 — GE HealthCare recently announced that its MIM KineticID modeling software1 is now 510(k) pending with the ...

Time May 29, 2026
arrow
News | SNMMI

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...

Time April 07, 2026
arrow
News | PET Imaging

March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...

Time April 06, 2026
arrow
News | FDA

March 18, 2026 — FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology, has announced that the U.S ...

Time March 24, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | PET-CT

Feb. 27, 2026 — A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little ...

Time February 26, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
Subscribe Now